Pioneers in Dermatology and Venereology: An Interview with Professor Peter van de Kerkhof

por van de Kerkhof, P.C.M.
Publicado 2021

Safety of treatment with biologics for psoriasis in daily practice: 5-year data

por Van Lümig, PPM, Driessen, RJB, Berends, MAM, Boezeman, J B, van de Kerkhof, PCM, de Jong, EMGJ
Publicado 2010

A European subset analysis from the population‐based Multinational Assessment of Psoriasis and Psoriatic Arthritis shows country‐specific features: results from psoriasis patients...

por Puig, L., van de Kerkhof, P.C.M., Reich, K., Bachelez, H., Barker, J., Girolomoni, G., Paul, C.
Publicado 2017

Quality of life outcomes in adults with moderate‐to‐severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study

por van de Kerkhof, P.C.M., Loewe, R., Mrowietz, U., Falques, M., Pau‐Charles, I., Szepietowski, J.C.
Publicado 2019

Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population‐based Multinational Assessment of Psoriasis and Psoriatic Arthritis surve...

por van de Kerkhof, P.C.M., Reich, K., Kavanaugh, A., Bachelez, H., Barker, J., Girolomoni, G., Langley, R.G., Paul, C.F., Puig, L., Lebwohl, M.G.
Publicado 2015

Frailty screening in dermato‐oncology practice: a modified Delphi study and a systematic review of the literature

por van Winden, M.E.C., Garcovich, S., Peris, K., Colloca, G., de Jong, E.M.G.J., Hamaker, M.E., van de Kerkhof, P.C.M., Lubeek, S.F.K.
Publicado 2020

Quality of life, treatment goals, preferences and satisfaction in older adults with psoriasis: a patient survey comparing age groups

por van Winden, M.E.C., ter Haar, E.L.M., Groenewoud, J.M.M., van de Kerkhof, P.C.M., de Jong, E.M.G.J., Lubeek, S.F.K.
Publicado 2020

Optimizing shared decision making in older adults with basal cell carcinoma: experiences from a specialized outpatient clinic

por van Winden, M.E.C., Klösters, F.M., Hamaker, M., Olde Rikkert, M.G., van de Kerkhof, P.C.M., de Jong, E.M.G.J., Lubeek, S.F.K.
Publicado 2021

Benefit–risk profile of tofacitinib in patients with moderate‐to‐severe chronic plaque psoriasis: pooled analysis across six clinical trials

por Strober, B.E., Gottlieb, A.B., van de Kerkhof, P.C.M., Puig, L., Bachelez, H., Chouela, E., Imafuku, S., Thaçi, D., Tan, H., Valdez, H., Gupta, P., Kaur, M., Frajzyngier, V., Wolk, R.
Publicado 2018